Ledger.Open graph →
SEC Form D · filed February 13, 2018

MABVAX THERAPEUTICS HOLDINGS, INC

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Kenneth M. Cohen · San Diego, CADirectorScott C. Telesz · New York, NYDirectorJ. David Hansen · San Diego, CAExec · DirectorMichael C. Mcghee · New York, NYDirectorBryen J. Salas · Tacoma, WADirectorPaul W. Resnick · San Diego, CAExecPaul W. Maffuid · San Diego, CAExecPhilip O. Livingston · San Diego, CADirectorThomas C. Varvaro · San Diego, CADirectorJeffrey F. Eisenberg · San Diego, CADirectorScott C. Hatton · New York, NYExecAndrew J. Gillespie-Smith · New York, NYDirectorBrett A. Hickey · New York, NYDirectorBrian C. Lofquist · Tacoma, WADirectorPaul Resnick · Lexington, MAExecScott M. Manson · TACOMA, WAExecMatthew C. Harris · New York, NYExec · DirectorJim T. Collord · Boise, IDExec · DirectorJoanne C. Salas · Tacoma, WADirectorBruce C. Maclennan · New York, NYExecPaul V. Maier · San Diego, CADirectorScott C. Stanley · New York, NYExecChristian J. Struzan · Tacoma, WAExecRajaram C. Rao · New York, NYDirectorAustin J. Gorst · Tacoma, WADirectorSalim C. Samaha · New York, NYDirectorGregory P. Hanson · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗